Ticker
LCTXCompany Name
LINEAGE CELL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 230.64M | $ 27.02M | $ -678K | $ 0 | -11.42% |
3/31/2025 | $ 107.33M | $ 27.12M | $ -450K | $ 0 | -24.85% |
12/31/2024 | $ 121.26M | $ 35.85M | $ -225K | $ 0 | -29.38% |
9/30/2024 | $ 167.12M | $ 14.05M | $ -53K | $ 0 | -8.37% |
6/30/2024 | $ 166.37M | $ 14.88M | $ -52K | $ 0 | -8.91% |
3/31/2024 | $ 222.78M | $ 20.64M | $ -54K | $ 0 | -9.24% |
12/31/2023 | $ 213.04M | $ 6.59M | $ -54K | $ 0 | -3.07% |
9/30/2023 | $ 187.24M | $ 6.59M | $ -50K | $ 0 | -3.49% |
6/30/2023 | $ 246.73M | $ 5.75M | $ -46K | $ 0 | -2.31% |
3/31/2023 | $ 239.95M | $ -46K | $ -37K | $ 0 | 0.03% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for LINEAGE CELL THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ -28K ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 25.11M ]) / Market Cap [ $ 181.49M ]
(=) Shareholder Yield [ -13.82% ]
Minimum
Dec 31, 2024
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.49K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |